English | Español

Amgen Inc.
Jamie Barrand | Feb 24, 2016

Romosozumab decreases spinal fracture risk in postmenopausal women, study indicates
Jamie Barrand | Feb 18, 2016

Anemia therapy study yields positive results
Jamie Barrand | Feb 9, 2016

Third trial of Repatha reveals positive results
Matt Smith | Jan 26, 2016

FDA to review application for Amgen's ABP 501 treatment
Jamie Barrand | Dec 27, 2015

Researchers unveil findings of acute lymphoblastic leukemia therapy trials
Jamie Barrand | Dec 18, 2015

Amgen reacquires rights to three GSK medications
Jamie Barrand | Dec 5, 2015

Amgen submits Marketing Authorization Application for ABP 501 to European Medicines Agency
Jamie Barrand | Oct 16, 2015

Amgen, Allergan launch Phase 3 study of biosimilar candidate ABP 215

Trending
+ Regulatory
C.D. Marsden | Apr 12, 2025

Empower Pharmacy: Eli Lilly lawsuit is ‘Big Pharma’s attempt to limit patient and provider choice’
+ Community
Patient Daily | Apr 17, 2025

ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+ Pharmaceuticals
Patient Daily | Apr 15, 2025

UCSF neurosurgeon: '340B is a drug discount program that hospitals exploit as an additional revenue stream'
+ Pharmaceuticals
Patient Daily | Apr 15, 2025

President of Drug Channels Institute: 'Hospital prices are significantly higher at large 340B hospitals'